Clinical analysis of anti-Ma2-associated encephalitis

Brain

Volumn 127, Issue 8, 2004, Pages 1831-1844

  Dalmau, Josep ^a   Graus, Francesc ^b   Villarejo, Alberto ^a,f   Posner, Jerome B ^c   Blumenthal, Deborah ^d   Thiessen, Brian ^e   Saiz, Albert ^b   Meneses, Patricio ^a   Rosenfeld, Myrna R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Brainstem; Diencephalic; Encephalitis; Limbic; Paraneoplastic

Indexed keywords

MA2 ANTIBODY; ONCOPROTEIN; OREXIN; PROTEIN ANTIBODY; PROTEIN MA2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATAXIA; BRAIN DISEASE; BRAIN DYSFUNCTION; BRAIN STEM; CATALEPSY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CRYPTORCHISM; DIENCEPHALON; ENCEPHALITIS; EYE MOVEMENT; FEMALE; FOLLOW UP; GAZE PARALYSIS; GERM CELL TUMOR; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LIMBIC CORTEX; LUNG CANCER; MALE; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; PARANEOPLASTIC NEUROPATHY; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SOMNOLENCE; SYNDROME DELINEATION; TESTIS; TUMOR DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; AUTOANTIBODIES; BRAIN STEM; ENCEPHALITIS; FEMALE; HUMANS; LIMBIC ENCEPHALITIS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASMS; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROTEINS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 4043101943     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh203     Document Type: Article

References (22)

1. Antoine JC, Honnorat J, Camdessanche JP, Magistris M, Absi L, Mosnier JF, et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 2001; 49: 214-21.
2. Barnett M, Prosser J, Sutton I, Halmagyi GM, Davies L, Harper C, et al. Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody. J Neurol Neurosurg Psychiatry 2001; 70: 222-5.
3. Bennett JL, Galetta SL, Frohman LP, Mourelatos Z, Gultekin SH, Dalmau JO. et al. Neuro-ophthalmologic manifestations of a paraneoplastic syndrome and testicular carcinoma. Neurology 1999; 52: 864-7.
4. Berkmen F, Alagol H. Germinal cell tumors of the testis in cryptorchids. J Exp Clin Cancer Res 1998; 17: 409-12.
5. Burton GV, Bullard DE, Walther PJ, Burger PC. Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer 1988; 62: 2248-51.
6. Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, et al. Mal, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999; 122: 27-39.
7. Derogee M, Bevers RF, Prins HJ, Jonges TG, Elbers FH, Boon TA. Testicular microlithiasis, a premalignant condition: prevalence, histopathologic findings, and relation to testicular tumor. Urology 2001; 57: 1133-7.
8. Dropcho EJ. Neurologic paraneoplastic syndromes. Curr Oncol Rep 2004; 6: 26-31.
9. Graus F, Keime-Guibert F, Reñé R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-48.
10. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123: 1481-94.
11. Henson RA, Urich HE, editors. Cancer and the nervous system. Oxford: Blackwell Scientific; 1982. p. 314-45.
12. Hierons R, Janota I, Corsellis JA. The late effects of necrotizing encephalitis of the temporal lobes and limbic areas: a clinico-pathological study of 10 cases. Psychol Med 1978; 8: 21-42.
13. Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 1996; 61: 270-8.
14. Landolfi JC, Nadkarni M. Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study. Neuro-oncology 2003; 5: 214-6.
15. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553-62.
16. Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, et al. Anti-Ma2 antibodies in idiopathic and paraneoplastic hypocretin-deficient narcolepsy. Neurology 2004; 62: 138-40.
17. Posner JB, editor. Neurologic complications of cancer. Philadelphia: F. A. Davis; 1995. p. 353-85.
18. Rojas I, Graus F, Keime-Guibert F, Reñé R, Delattre JY, Ramón JM, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 2000; 55: 713-5.
19. Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 2001; 50: 339-48.
20. Sutton I, Winer J, Rowlands D, Dalmau J. Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer. J Neurol Neurosurg Psychiatry 2000; 69: 266-8.
21. Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, Posner JB, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999; 340: 1788-95.
22. Wong AM, Musallam S, Tomlinson RD, Shannon P, Sharpe JA. Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 2001; 189: 71-81.